Funding: By Researcher » Funding » Department of Ophthalmology Research » College of Medicine

The strength of our research team here in the Department of Ophthalmology is highlighted, in part, by their funding.

John D Ash PhD

Eminent Scholar

Grants:

Sep 2021 ACTIVE
Transcriptional control of stress-induced resistance to retinal degeneration
NATL INST OF HLTH NEI · Principal Investigator

Sep 2021 ACTIVE
Role of Caveolin-1 in the maintenance of blood-retinal barrier integrity.
UNIV OF OKLAHOMA HEALTH SCIENCES CTR · Principal Investigator

Mar 2021 ACTIVE
Retinal Degeneration Conference
NATL INST OF HLTH NEI · Principal Investigator

Sep 2020 ACTIVE
Regulators of retinal metabolism in healthy and degenerating retinas
NATL INST OF HLTH NEI · Principal Investigator

Sep 2016 – May 2020
Comparative transcriptomic and epigenomic analysis of Muller glia reprogramming
UNIV OF NOTRE DAME · Principal Investigator

Jun 2016 – Jun 2019
Developing AAV vectors for drug-regulated expression of neuroprotective factors to induce broad spectrum protection of photoreceptors and RPE.
FOU FOR FIGHTING BLINDNESS · Principal Investigator

Feb 2014 – Jan 2018
Cytokine Regulation of Photoreceptor Gene Expression
NATL INST OF HLTH NEI · Principal Investigator

Jun 2013 – Jun 2016
Using AAV-STAT3 and AAV-PIM-1 vectors to induce broad-spectrum protection of photoreceptors and RPE
FOU FOR FIGHTING BLINDNESS · Principal Investigator

Aug 2011 – Jul 2016
Vision Research Core
NATL INST OF HLTH NEI · Project Manager

May 2007 ACTIVE
Overstreet Retinal Eye Disease Research
UF FOUNDATION · Project Manager

Full Profile

Astra Dinculescu PhD

Assistant Professor

Grants:

Jun 2021 ACTIVE
Generation and Characterization of Swine Models of Usher Syndrome Type 3
FOU FOR FIGHTING BLINDNESS · Principal Investigator

Sep 2019 ACTIVE
Transcriptional control of proteostasis in photoreceptors
NATL INST OF HLTH NEI · Co-Investigator

Jul 2017 – Aug 2019
The role of basal C1QTNF5-S163R mutant deposits in drusen formation: implications for AMD
BRIGHTFOCUS FOU · Principal Investigator

Sep 2016 ACTIVE
CLARIN 1 RETINAL FUNCTION AND THERAPEUTIC IMPLICATIONS FOR USH3
NATL INST OF HLTH NEI · Principal Investigator

Full Profile

Frank M Dyka PhD

Assistant Scientist

Grants:

Jul 2021 – Dec 2021
Production of condensed scAAV vectors for adRP
IVERIC BIO · Principal Investigator

Oct 2020 – Mar 2021
Production of a Lentivirus RHO-GFP Vector
IVERIC BIO · Principal Investigator

Aug 2020 ACTIVE
Non-GLP Expression Study in C57BL/6 Mice
APPLIED GENETICS TECH CORP · Principal Investigator

Jan 2019 – Dec 2019
Dual Vectors for Otoferlin
DECIBEL THERAPEUTICS · Co-Investigator

Full Profile

William W Hauswirth PhD

Eminent Scholar

Grants:

Feb 2020 – Aug 2021
Preclinical Validation for ADVM-062 in Knock-Out and C198R Knock-In Missense Mouse Models of BCM
ADVERUM BIOTECHNOLOGIES INC · Principal Investigator

Sep 2019 – Mar 2021
Disease mechanisms of cone opsin mutants and treatment strategies
NATL INST OF HLTH NEI · Co-Investigator

Mar 2019 ACTIVE
Mito-Targeted AAV to Treat Leber Hereditary Optic Neuropathy Caused by ND4 Mutations
UNIV OF MIAMI · Principal Investigator

Jan 2019 – Dec 2019
Dual Vectors for Otoferlin
DECIBEL THERAPEUTICS · Principal Investigator

Jun 2018 – Jun 2019
Gene Therapy for RHO adRP
IVERIC BIO · Faculty

Apr 2018 ACTIVE
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa
MICHIGAN STATE UNIV · Principal Investigator

Oct 2017 – Mar 2019
Toxicology Study of BS01 in Rd1 mice
APPLIED GENETICS TECH CORP · Project Manager

Sep 2016 – Aug 2021
Translational Research for Retinal Degenerative Therapies
UNIV OF PENNSYLVANIA · Principal Investigator

Aug 2016 ACTIVE
Testing Gene Therapy in Models of Geographic Atrophy
NATL INST OF HLTH NEI · Faculty

Jul 2016 – Oct 2017
XLRP Mouse Toxicology Study
APPLIED GENETICS TECH CORP · Faculty

Jan 2016 – Feb 2018
AAV-Mediated Therapy for Best Vitelliform Macular Dystrophy
UNIV OF PENNSYLVANIA · Principal Investigator

Oct 2015 – Oct 2016
DSR Match Support – Gene Therapy for ABCA4 Stargar
UF DIV OF SPONSORED RES MATCHING FUNDS · Principal Investigator

Sep 2015 – Sep 2018
blue cone monochromancy
APPLIED GENETICS TECH CORP · Principal Investigator

Sep 2015 – Aug 2016
Translational Research for Retinal Degenerative Therapies
UNIV OF PENNSYLVANIA · Principal Investigator

May 2015 – Mar 2020
Gene Therapy for ABCA4 Stargardt's Disease
APPLIED GENETICS TECH CORP · Principal Investigator

Jan 2015 – Jun 2018
Gene Therapy for Blue Cone Monochromacy
BCM Families Foundation · Principal Investigator

Jun 2013 – Nov 2019
rAAV-CNGB3 Gene Therapy for Achromatopsia: Translational Research Studies
NATL INST OF HLTH NEI · Principal Investigator

Feb 2013 – Jan 2018
Population Coding in the Retina
CORNELL UNIV · Principal Investigator

Jan 2013 – Dec 2021
Vitreal delivery of novel AAV vectors for blue cone monochromacy gene therapy
UF FOUNDATION · Principal Investigator

Nov 2012 – Dec 2016
XIAP gene therapy for the treatment of retinal degeneration: Safety and toxicity studies for translation into the clinic
OTTAWA HOSP RESEARCH INST · Principal Investigator

Oct 2012 – Sep 2016
Gene therapy using novel cone-targeted adeno-associated vital vectors in the CNGA3 sheep model of achromatopsia
US ISRAEL BINATIONAL SCI FOU · Principal Investigator

Aug 2012 – Jul 2018
Gene Therapy for CEP290 LCA and RPE Dystrophies
FOU FOR FIGHTING BLINDNESS · Principal Investigator

Mar 2012 – Feb 2018
Translational Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa (Module 1)
UNIV OF PENNSYLVANIA · Principal Investigator

Oct 2011 – Jun 2016
Gene Therapy for LCA1
FOU FOR FIGHTING BLINDNESS · Principal Investigator

Aug 2011 – Jul 2016
Vision Research Core
NATL INST OF HLTH NEI · Principal Investigator

Jul 2011 – Jun 2016
Module 1: Cone Targeted Gene Therapy
FOU FOR FIGHTING BLINDNESS · Principal Investigator

Jan 2011 – Jan 2021
Purified Recombinant Adeno Associated Virus
MULTIPLE SPONSORS · Principal Investigator

Jan 2004 – May 2017
03091205
MACULAR VISION RESEARCH FOU · Principal Investigator

Full Profile

Cristhian J Ildefonso PhD

Assistant Professor

Grants:

Jul 2019 ACTIVE
Gene Therapy for Bestrophinopathies – Silent and Replace BEST
IVERIC BIO · Principal Investigator

Jul 2017 – Sep 2019
Local and Systemic Inflammation in a Mouse Model of RPE-oxidative Damage
BRIGHTFOCUS FOU · Principal Investigator

Aug 2016 ACTIVE
Testing Gene Therapy in Models of Geographic Atrophy
NATL INST OF HLTH NEI · Faculty

Full Profile

Qiuhong Li PhD

Associate Professor

Grants:

Dec 2021 ACTIVE
Role of Ang(17)-secreting Lactobacillus paracasei (LP) in regulating Hypertension: Piloting Dosing Strategies
WAKE FOREST UNIV · Principal Investigator

Sep 2019 – Aug 2021
Optimization of food-grade recombinant probiotics for oral delivery of ACE2/Ang-(1-7)
MEDOSOME BIOTEC · Co-Investigator

Jun 2019 – May 2021
Fee for Service Contract with University of Alabama (UAB)
UNIV OF ALABAMA BIRMINGHAM · Principal Investigator

May 2018 – Apr 2022
ACE2 Modulates the Bone Marrow- Gut Axis in Diabetic Retinopathy
UNIV OF ALABAMA BIRMINGHAM · Principal Investigator

Aug 2016 – Dec 2021
ACE2, Brain, Gut Dysbiosis in Pulmonary Hypertension
NATL INST OF HLTH NHLBI · Co-Investigator

Sep 2015 – Aug 2020
Oral therapy for diabetic retinopathy using ACE2/Ang1-7 bioencapsulated in plant cells
NATL INST OF HLTH NEI · Principal Investigator

Jul 2015 – Jun 2017
Ang-(1-7)/Mas Signaling in Aging Eye- Protective Mechanisms and Therapeutic Potential
BRIGHTFOCUS FOU · Principal Investigator

Jan 2015 – Dec 2017
Oral delivery of bioencapsulated ACE2 and Ang1-7 for therapy of diabetic retinopathy
AMER DIABETES ASSOCIATION · Principal Investigator

Jan 2012 – Dec 2016
Ocular Renin Angotensin System in Pathogenesis of Diabetic Retinopathy
NATL INST OF HLTH NEI · Principal Investigator

Full Profile

Ekaterina Lobanova PhD

Assistant Professor

Grants:

Sep 2019 ACTIVE
Transcriptional control of proteostasis in photoreceptors
NATL INST OF HLTH NEI · Principal Investigator

Full Profile

Mark B Sherwood MD

Emeritus Professor

Grants:

Jun 2017 – May 2019
OR-DRPD-ROF2017: Novel Glaucoma Drainage Devices
UF DSR OPPORTUNITY FUND · Co-Investigator

Oct 2015 – Jun 2019
Glaucoma Therapy by Contact Lenses-Human Trials
UF DSR OPPORTUNITY FUND · Principal Investigator

Feb 2015 – Aug 2019
192024-092 The Efficacy and Safety of Bimatoprost SR in Patients with Open-angle Glaucoma or Ocular Hypertension
ALLERGAN plc · Principal Investigator

Aug 2006 ACTIVE
UFF Daniels Professorship
UF FOUNDATION · Principal Investigator

Full Profile

W. Clay Smith PhD

Associate Professor

Grants:

Apr 2022 ACTIVE
Biological assay of sterilant bioactivity in tissue culture
MICHELSON FOUND ANIMALS FOUNDATION · Principal Investigator

Jan 2022 ACTIVE
SBT-100 Regulation of Cytokine Signaling and Autoimmunity
SINGH BIOTECHNOLOGY · Co-Project Director/Principal Investigator

Apr 2021 ACTIVE
Mitigation of Equine Recurrent Uveitis through topical suppressor of Cytokine Signaling-1 mimetic peptide
GRAYSON JOCKEY CLUB RES FOU · Co-Investigator

Nov 2020 – Jun 2021
Task Order #3 – Biological assay of sterilant bioactivity in tissue culture
MICHELSON FOUND ANIMALS FOUNDATION · Principal Investigator

Sep 2020 – Sep 2021
Core Equipment for Assessment of Ocular Disease in Animal Models
NATL INST OF HLTH OD · Principal Investigator

Jun 2020 – Nov 2020
Task Order #2 – Biological assay of sterilant bioactivity in tissue culture
MICHELSON FOUND ANIMALS FOUNDATION · Principal Investigator

Sep 2019 – Mar 2021
Disease mechanisms of cone opsin mutants and treatment strategies
NATL INST OF HLTH NEI · Co-Investigator

Jul 2019 – Feb 2020
Task Order #1 – Sterilant Bioassay for Michelson Found Animals Foundation
MICHELSON FOUND ANIMALS FOUNDATION · Principal Investigator

Jun 2019 ACTIVE
Enhancing Metabolism in Photoreceptors with a Modified Arrestin to Treat Retinal Degeneration
FOU FOR FIGHTING BLINDNESS · Principal Investigator

Mar 2016 – Feb 2022
Research Training in vision science
NATL INST OF HLTH NEI · Principal Investigator

Aug 2011 – Jul 2016
Vision Research Core
NATL INST OF HLTH NEI · Project Manager

Full Profile

Sonal S Tuli MD

Professor And Chair

Grants:

Apr 2021 ACTIVE
Mitigation of Equine Recurrent Uveitis through topical suppressor of Cytokine Signaling-1 mimetic peptide
GRAYSON JOCKEY CLUB RES FOU · Co-Investigator

Dec 2020 ACTIVE
A Double-Masked, Randomised, Placebo-Controlled, Parallel Group, 12-week, Phase 2 study to investigate the safety and Efficacy of Ripasudil (K-321) Eye Drops After Descemetorhexis in Patients with Fuchs Endothelial Corneal Dystrophy
PPD INVESTIGATOR SERVICES LLC · Principal Investigator

Aug 2017 – Jun 2021
Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus
NEW YORK UNIVERSITY SCHOOL OF MEDICINE · Principal Investigator

May 2016 – Mar 2021
An Observational, Multicenter Study of the Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patient Populations Diagnosed with Early-Onset Idiopathic Bilateral Cataracts Protocol Number 018CTXX15001
CTI CLINICAL TRIAL SERVICES · Principal Investigator

Dec 2014 – Dec 2017
Clinical Evaluation of the RPS-OH to detect Herpes Simplex Virus
RAPID PATHOGEN SCREENING · Principal Investigator

Sep 2014 – Aug 2016
Regulation of Stromal Wound Healing by Growth Factors
NATL INST OF HLTH NEI · Project Manager

Feb 2011 – Feb 2020
Stanley Glaucoma Fund
UF FOUNDATION · Project Manager

Aug 2007 – Dec 2020
Lion's Eye Foundation Award
NORTH FL LIONS EYE FOU · Principal Investigator

Jul 2007 – Oct 2020
Retina Disease Research & Education- Equipment Purchases
UF FOUNDATION · Principal Investigator

Jul 2007 – Dec 2020
Unrestricted Research Grant
RESEARCH TO PREVENT BLINDNESS · Principal Investigator

May 2007 ACTIVE
Overstreet Retinal Eye Disease Research
UF FOUNDATION · Principal Investigator

Full Profile